7th April 2026 PharmaZenBiotechnology company PharmaZen is in receivership, with the bank-initiated move prompting a clap-back from the company’s board.
3rd March 2026 Investment / PharmaZenBiotechnology company PharmaZen has suspended trading as it enters high-stakes negotiations with an international suitor for a potential major investment.
29th April 2025 Manufacturing / PharmaZenChristchurch biotechnology company says US President Donald Trump’s new tariff regime presents a “compelling opportunity” for the manufacturer.
29th November 2024 PharmaZen / SFFFThe government is investing in a two-year project with PharmaZen to add value to New Zealand’s blackcurrant industry by piloting a processing facility in Canterbury.
21st August 2024 PharmaZenFirst-half sales at Christchurch biotechnology company PharmaZen came it at $13.7m, with underlying EBITDA of $620k for the period to 30 June.
4th July 2024 PharmaZenChristchurch biotechnology company PharmaZen is upbeat about its prospects for the 2024 financial year, claiming strong sales to start the year.
31st May 2024 PharmaZenChristchurch biotechnology company PharmaZen posted full year revenue and underlying earnings growth supported by investment in new capacity and strong demand for its range of nutraceuticals and supplements.
16th August 2023 PharmaZenChristchurch biotechnology company PharmaZen reported a disappointing result for the six months to 30 June 2023, following significant staffing issues in the first quarter.
20th June 2023 PharmaZenChristchurch biotechnology company PharmaZen says it has successfully filled 15 vacancies this year, which will help it overcome a poor first half of FY23 due to labour shortages.
16th May 2023 PharmaZenThe Christchurch biotechnology company delivers a strong post-Covid turnaround in 2022 despite battling supply chain snarl-ups and labour shortages.
18th August 2022 PharmaZen / VMSChristchurch biotechnology company PharmaZen, which trades as Waitaki Biosciences, saw revenue jump 36% to $12.8m in the first half to 30 June 2022.
1st June 2022 Ingredient / PharmaZenThe 2021 financial year was one of “running in quicksand,” says Craig McIntosh, managing director of PharmaZen, which trades as Waitaki Biosciences.
